"Surgery is not right for every patient with Type 2 diabetes. The very success of the surgery in improving or even resolving the disease is what makes the need for new guidelines so urgent," says Dr. Lebovitz.
Cardiovascular Risk and Longevity
The connection between diabetes and heart disease is so strong that some consider diabetes a cardiovascular disease on its own. For a diabetes treatment to be successful, then, it must go beyond blood sugar regulation alone. "It must bring patients' physiology into long-term balance so as to significantly lower their risk of cardiovascular disease, the leading cause of death in the United States and worldwide," says Dr. Rubino.
New data on the long-term reduction of cardiovascular risk and overall survival after metabolic surgery will be presented at the Congress. In one presentation, Dr. Lars Sjstrm, professor at the Institute of Medicine in Gteborg, Sweden, will provide an update from the Swedish Obesity Study (SOS) after 20 years since its inception. The longest study of its kind, SOS has compared more than 2,010 bariatric surgeries for weight loss to a similar number of patients undergoing conservative (lifestyle or medical) treatments. The results presented at the Congress will show that bariatric surgery outperformed non-surgical approaches with respect to long-term weight loss, control of high blood sugar, decrease in cardiovascular risk, and overall survival.
"The next step will be to design multicenter, randomized, controlled trials comparing patients grouped by body weight who are receiving gastric bypass for Type 2 diabetes with those being treated non-surgically," says Dr. David Cummings, a leading endocrinologist and professor of medicine at the University of Washington in Seattle. "We ha
|Contact: Takla Boujaoude |
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College